Literature DB >> 10931442

Posttranslationally modified bacteriocins--the lantibiotics.

A Guder1, I Wiedemann, H G Sahl.   

Abstract

Lantibiotics are a subgroup of bacteriocins that are characterized by the presence of the unusual thioether amino acids lanthionine and 3-methyllanthionine generated through posttranslational modification. The biosynthesis of lantibiotics follows a defined pathway comprising modifications of the prepeptide, proteolytic activation, and export. The genes encoding the biosynthesis apparatus and the lantibiotic prepeptide are organized in clusters, which also include information for proteins involved in regulation and producer self-protection. The elongated cationic lantibiotics primarily act through the formation of pores and recent progress with nisin and epidermin has shown that specific docking molecules such as lipid II play an essential role in this mechanism. Mersacidin and actagardine inhibit cell wall biosynthesis by complexing the precursor lipid II, whereas the cinnamycin-like peptides bind to phosphoethanolamine thus inhibiting phospholipase A2. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931442     DOI: 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  33 in total

1.  Improvement of multiple-stress tolerance and lactic acid production in Lactococcus lactis NZ9000 under conditions of thermal stress by heterologous expression of Escherichia coli DnaK.

Authors:  Shinya Sugimoto; Chihana Higashi; Shunsuke Matsumoto; Kenji Sonomoto
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

Review 2.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Multidimensional signatures in antimicrobial peptides.

Authors:  Nannette Y Yount; Michael R Yeaman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 4.  Strategies for the use of bacteriocins in Gram-negative bacteria: relevance in food microbiology.

Authors:  Cláudia Vieira Prudêncio; Miriam Teresinha Dos Santos; Maria Cristina Dantas Vanetti
Journal:  J Food Sci Technol       Date:  2015-02-11       Impact factor: 2.701

5.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic.

Authors:  Judicaël Parisot; Sarah Carey; Eefjan Breukink; Weng C Chan; Arjan Narbad; Boyan Bonev
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

7.  Bovicin HC5, a lantibiotic produced by Streptococcus bovis HC5, catalyzes the efflux of intracellular potassium but not ATP.

Authors:  Hilário C Mantovani; James B Russell
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

8.  An unusual mutation results in the replacement of diaminopimelate with lanthionine in the peptidoglycan of a mutant strain of Mycobacterium smegmatis.

Authors:  Sandra A Consaul; Lori F Wright; Sebabrata Mahapatra; Dean C Crick; Martin S Pavelka
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

9.  Genes involved in SkfA killing factor production protect a Bacillus subtilis lipase against proteolysis.

Authors:  Helga Westers; Peter G Braun; Lidia Westers; Haike Antelmann; Michael Hecker; Jan D H Jongbloed; Hirofumi Yoshikawa; Teruo Tanaka; Jan Maarten van Dijl; Wim J Quax
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

10.  Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI.

Authors:  Lorraine A Draper; Lucy H Deegan; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.